Definition and classification of cancer cachexia: an international consensus

Moses, 2004, Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids, Br J Cancer, 90, 996, 10.1038/sj.bjc.6601620 Bachmann, 2008, Cachexia worsens prognosis in patients with resectable pancreatic cancer, J Gastrointest Surg, 12, 1193, 10.1007/s11605-008-0505-z Dewys, 1980, Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group, Am J Med, 69, 491, 10.1016/S0149-2918(05)80001-3 Fearon, 2006, Definition of cancer cachexia: effect of weight loss, reduced food intake and systemic inflammation on functional status and prognosis, Am J Clin Nutr, 83, 1345, 10.1093/ajcn/83.6.1345 Churm, 2009, A questionnaire study of the approach to the anorexia-cachexia syndrome in patients with cancer by staff in a district general hospital, Support Care Cancer, 17, 503, 10.1007/s00520-008-0486-1 Spiro, 2006, The views and practice of oncologists towards nutritional support in patients receiving chemotherapy, Br J Cancer, 95, 431, 10.1038/sj.bjc.6603280 Pacelli, 2008, Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery?, Clin Nutr, 27, 398, 10.1016/j.clnu.2008.03.002 Hopkinson, 2006, The prevalence of concern about weight loss and change in eating habits in people with advanced cancer, J Pain Symptom Manage, 32, 322, 10.1016/j.jpainsymman.2006.05.012 Fearon, 2008, Cancer cachexia: developing multimodal therapy for a multidimensional problem, Eur J Cancer, 44, 1124, 10.1016/j.ejca.2008.02.033 Kaasa, 2008, Symptom assessment in palliative care: a need for international collaboration, J Clin Oncol, 26, 3867, 10.1200/JCO.2007.15.8881 Yavuzsen, 2005, Systematic review of the treatment of cancer-associated anorexia and weight loss, J Clin Oncol, 23, 8500, 10.1200/JCO.2005.01.8010 Bosaeus, 2008, Nutritional support in multimodal therapy for cancer cachexia, Support Care Cancer, 16, 447, 10.1007/s00520-007-0388-7 Kubrak, 2010, Nutrition impact symptoms: key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment, Head Neck, 32, 290 Chopard, 2009, Molecular events and signalling pathways involved in skeletal muscle disuse-induced atrophy and the impact of countermeasures, J Cell Mol Med, 13, 3032, 10.1111/j.1582-4934.2009.00864.x Paddon-Jones, 2006, Atrophy and impaired muscle protein synthesis during prolonged inactivity and stress, J Clin Endocrinol Metab, 91, 4836, 10.1210/jc.2006-0651 Reid, 2010, An exploration of the experience of cancer cachexia: what patients and their families want from healthcare professionals, Eur J Cancer Care (Engl), 19, 682, 10.1111/j.1365-2354.2009.01124.x Hawkins, 2009, Quantifying the impact of standardized assessment and symptom management tools on symptoms associated with cancer-induced anorexia cachexia syndrome, Palliat Med, 23, 680, 10.1177/0269216309106980 Strasser, 2007, Appraisal of current and experimental approaches to the treatment of cachexia, Curr Opin Support Palliat Care, 1, 312, 10.1097/SPC.0b013e3282f3474c Argilés, 2007, Mechanisms to explain wasting of muscle and fat in cancer cachexia, Curr Opin Support Palliat Care, 1, 293, 10.1097/SPC.0b013e3282f34738 Senior, 2007, Why is progress in treatment of cancer cachexia so slow?, Lancet Oncol, 8, 671, 10.1016/S1470-2045(07)70222-X Fox, 2009, Estimation of cachexia among cancer patients based on four definitions, J Oncol, 10.1155/2009/693458 Jatoi, 2008, Weight loss in patients with advanced cancer: effects, causes, and potential management, Curr Opin Support Palliat Care, 2, 45, 10.1097/SPC.0b013e3282f4b734 Evans, 2008, Cachexia: a new definition, Clin Nutr, 27, 793, 10.1016/j.clnu.2008.06.013 Strasser, 2008, Diagnostic criteria of cachexia and their assessment: decreased muscle strength and fatigue, Curr Opin Clin Nutr Metab Care, 11, 417, 10.1097/MCO.0b013e3283025e27 Bozzetti, 2009, Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group, JPEN J Parenter Enteral Nutr, 33, 361, 10.1177/0148607108325076 Biondo, 2008, Applying the Delphi process to palliative care tool development: lessons learned, Support Care Cancer, 16, 935, 10.1007/s00520-007-0348-2 Fainsinger, 2009, Is pain intensity a predictor of the complexity of cancer pain management?, J Clin Oncol, 27, 585, 10.1200/JCO.2008.17.1660 Kitzinger, 1995, Qualitative research. Introducing focus groups, BMJ, 311, 299, 10.1136/bmj.311.7000.299 Prado, 2009, The emerging role of computerized tomography in assessing cancer cachexia, Curr Opin Support Palliat Care, 3, 269, 10.1097/SPC.0b013e328331124a Prado, 2007, Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity, Clin Cancer Res, 13, 3264, 10.1158/1078-0432.CCR-06-3067 Jette, 1983 Baumgartner, 1998, Epidemiology of sarcopenia among the elderly in New Mexico, Am J Epidemiol, 147, 755, 10.1093/oxfordjournals.aje.a009520 Prado, 2008, Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study, Lancet Oncol, 9, 629, 10.1016/S1470-2045(08)70153-0 Janssen, 2002, Low relative skeletal muscle mass (sarcopenia) in older persons associated with functional impairment and physical disability, J Am Geriatric Soc, 50, 889, 10.1046/j.1532-5415.2002.50216.x Read, 2005, Nutritional assessment in cancer: comparing the Mini-Nutritional Assessment (MNA) with the scored Patient-Generated Subjective Global Assessment (PGSGA), Nutr Cancer, 53, 51, 10.1207/s15327914nc5301_6 Tan, 2009, Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer, Clin Cancer Res, 15, 6973, 10.1158/1078-0432.CCR-09-1525 Prado, 2009, Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastic breast cancer patients receiving capecitabine treatment, Clin Cancer Res, 15, 2920, 10.1158/1078-0432.CCR-08-2242 Muscaritoli, 2010, Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”, Clin Nutr, 29, 154, 10.1016/j.clnu.2009.12.004 Lieffers, 2009, A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands, Am J Clin Nutr, 89, 1173, 10.3945/ajcn.2008.27273 Orrevall, 2009, The use of artificial nutrition among cancer patients enrolled in palliative home care services, Palliat Med, 23, 556, 10.1177/0269216309105811 Fearon, 2006, Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia, J Clin Oncol, 24, 3401, 10.1200/JCO.2005.04.5724 Strasser, 2008, Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study, Br J Cancer, 98, 300, 10.1038/sj.bjc.6604148 Sharma, 2009, A proposed clinical staging system for obesity, Int J Obes (Lond), 33, 289, 10.1038/ijo.2009.2 Yavuzsen, 2009, Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia, Support Care Cancer, 17, 1531, 10.1007/s00520-009-0623-5 Deans, 2009, Cancer cachexia is associated with the IL10-1082 gene promoter polymorphism in patients with gastroesophageal malignancy, Am J Clin Nutr, 89, 1164, 10.3945/ajcn.2008.27025 Argilés, 2009, The role of cytokines in cancer cachexia, Curr Opin Support Palliat Care, 3, 263, 10.1097/SPC.0b013e3283311d09 Weber, 2009, Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia, Acta Oncol, 48, 116, 10.1080/02841860802130001 Strasser, 2007, Fighting a losing battle: eating-related distress of men with advanced cancer and their female partners. A mixed-methods study, Palliat Med, 21, 129, 10.1177/0269216307076346